Cephalosporins Flashcards
Cephalosporin General Facts
Have some cross allergenicity with penicillins
Cross reactivity quoted at 10% but reasonable estimate is 3-5% but less for later generations
Be skeptical of nausea
Take hives and anaphylaxis seriously
Similar side chains may be responsible for cross reactivity
Generally more resistant to betalactamses than penicillins
Cephalosporinases exist and are becoming more prevalent (in contrast to penicillinases)
First Generation Cephalosporins
Oral
Cephalexin
Cefadroxil
IV
Cefazolin
Cephalothin
Used immediately prior to surgery to prevent surgical site infections; most commonly used class in the hospital Ideal because of spectrum, cheap, low incidence of adverse effects Useful for treating skin and skin structure infections
First Generation Cephalosporins Spectrum
Good
MSSA
Streptococci
Moderate
Some enteric GNRs
Poor Enterococci Anaerobes MRSA Pseudomonas
First Generation Cephalosporins Important Facts
Good alternatives to antistaphylococcal penicillins
Cause less phlebitis; infused less frequently
Unlike them, may not cross the blood brain barrier;
Should not be used in CNS infections
Good for Skin and skin structure infections Surgical prophylaxis (usually should not give more than one dose; giving more than 24 hours of therapy is rarely justified-does not lower infection rates but may select for more resistant organisms later in the hospital stay) Staphylococcal bloodstream infections Osteomyelitis Endocarditis (MSSA)
Second Generation Cephalosporins
Oral
Cefaclor
Cefprozil
Loracarbef
IV Cefoxitin Cefotetan Cefmetazole Cefonicid Cefamandole
Oral and IV
Cefuroxime
Better Gram- activity; somewhat weaker Gram+ activity but still used for these organisms
More stable against Gram- betalactamases and particular active against H. influenzae and N. gonorrhoeae
Most numerous cephalosporins but least utilized in the US
Second Generation Cephalosporins Spectrum
Good
Some enteric GNRs
Haemophilus
Neisseria
Moderate
Streptococci
Staphylococci
Anaerobes (only cefmetazole, cefotetan, cefoxitin)
Poor
enterococci
MRSA
Pseudomonas
Second Generation Cephalosporins Adverse Effects
Ceph with N-methylthiotetrazole (MTT) side chain can inhibit vitamin K production and prolong bleeding (cefmetazole, cefotetan, cefamandole)
Can also cause a disulfiram like reaction when given ethanol
Second Generation Cephalosporins Important Facts
Cephamycins (cefmetazole, cefotetan, cefoxitin)
Have activity against many anaerobes in GI tract
Cefoxitin and Cefotetan often used for surgical prophylaxis in abdominal surgery
Loracarbef is a carbacepbem
Do not cross the blood brain barrier well enough to be used in CNS infections (like the first gen ceph)
Good for Upper respiratory tract infections Community acquired pneumonia Gonorrhea Surgical prophylaxis (cephamycins)
Cephamycins have good intrinsic anaerobic activity but resistance is increasing in Bacteroides fragilis group infections
In surgical prophylaxis, limit duration after surgery
If infection develops, use an alternative (beta lactamase inhibitor combination or another Gram- agent with metronidazole)
Third Generation Cephalosporins
Greater Gram- coverage than 1G and 2G
Good strep activity but less staph than previous generations
Considered broad spectrum agents
Ceftriaxone Cefotaxime Ceftazidime Cefdinir Cefpodoxime Cefixime Ceftibuten
Third Generation Cephalosporins Spectrum
Good
Streptococci (ceftazidime is poor)
Enteric GNRs
Pseudomonas (only ceftazidime)
Moderate
MSSA (ceftazidime is poor)
Poor Enterococci Pseudomonas (except ceftazidime) Anaerobes MRSA
Third Generation Cephalosporins Adverse Effects
One of the classes with strongest association with Clostridium difficile associated diarrhea
Cefpodoxime has MTT side chain that can inhibit vitamin K production
Third Generation Cephalosporins Important Facts
Ceftazidime is unique
Is antipseudomonal
Lacks clinically useful activity against Gram+ organisms
Ceftriaxone, cefotaxime, ceftazidime cross the blood brain barrier effectively
Useful for CNS infections
Don’t use ceftazidime for community acquired meningitis where S. Pneumoniae predominates
Notorious for inducing resistance among GNRs
Too much broad spectrum usage can result in harder to treat infections
Ceftriaxone one time IM dose increased from 125 to 250mg for gonnorhea (drug of choice)
Should also receive azithromycin (empiric therapy for chlamydia and may reduce emergence of ceftriaxone resistance
Ceftriaxone has dual modes of elimination (renal and biliary excretion)
Does not need to renally adjusted but does effectively treat UTIs
Cefotaxime is safer than ceftriaxone for neonate for two reasons
- Interacts with calcium containing medications to form crystals; can precipitate in lungs and kidneys leading to fatalities
- Can lead to biliary sludging with resultant hyperbilirubinemia
Give higher doses of ceftriaxone (2-4g per day) for MSSA (especially invasive infections)
Need higher doses due to less activity against this organism
Ceftriaxone is a once daily drug for almost all indications except meningitis
2g IV q12H
High dose used for meningitis mainly and a few more indications
Use vancomycin and ampicillin if indicated
Good for Lower respiratory tract infections Pyelonephritis Nosocomial infections (ceftazidime) Lyme disease (ceftriaxone) Meningitis Gonorrhea Skin and skin structure infections Febrile neutropenia (ceftazidime)
Fourth Generation Cephalosporins
Cefepime
Broadest spectrum ceph
Cefazolin (1st) + Ceftazidime (3rd) = Cefepime (4th)
Has activity against Gram- (including Pseudomonas) and Gram+ organisms
Fourth Generation Cephalosporins Spectrum
Good MSSA Streptococci Pseudomonas Enteric GNRs
Moderate
Acinetobacter
Poor
Enterococci
Anaerobes
MRSA
Fourth Generation Cephalosporins Important Facts
May be associated with more neurotoxicity compared with other agents
May manifest as nonconvulsive status epilepticus
Can occur at any dose; still need to adjust dose in renal dysfunction
Good empiric choice for many nosocomial infections; overkill for community acquired infections
Deescalate if possible
Cefepime is better choice than ceftazidime for mono therapy of febrile neutropenia
Better Gram+ activity
May induce less resistance in GNRs
Initially meta analysis showed increased mortality compared with other drugs
FDA exonerated it
Good for Febrile neutropenia Nosocomial pneumonia Postneurosurgical meningitis Other nosocomial infections
Used primarily for nosocomial infections
Overkill for community acquired urinary tract and lower respiratory tract infections